Orchestra BioMed (OBIO) Misses Q3 EPS by 40c
Tweet
Share
E-mailGet Alerts OBIO Hot Sheet
Join SI Premium – FREE
Orchestra BioMed (NASDAQ: OBIO) reported Q3 EPS of ($0.40). Revenue for the quarter came in at $900 thousand.
For earnings history and earnings-related data on Orchestra BioMed (OBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
- Barclays Downgrades Renault SA (RNO:FP) (RNSDF) to Equalweight
- UBS Starts Urban Company (URBANCO:IN) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
